Kimberly M Thompson Selected Research

Oral Poliovirus Vaccine (Sabin Vaccine)

11/2021	Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options.
4/2021	The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
1/2021	Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV.
1/2021	A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID-19 in the United States.
1/2021	Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame.
1/2019	Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV).
1/2018	Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine.
1/2018	Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.
1/2016	Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
1/2016	Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimberly M Thompson Research Topics

Disease

47	Poliomyelitis (Polio) 10/2022 - 12/2006
10	Measles 01/2017 - 07/2012
9	Rubella (German Measles) 01/2017 - 07/2012
7	Infections 01/2016 - 04/2013
3	COVID-19 11/2021 - 01/2021
2	Vaccine-Preventable Diseases 01/2016 - 06/2010
2	Reinfection 01/2016 - 04/2013
1	Wounds and Injuries (Trauma) 01/2020
1	Shoulder Injuries 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Mumps 01/2017
1	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 01/2016
1	Primary Immunodeficiency Diseases 09/2015
1	Drowning 03/2003
1	Whooping Cough (Pertussis) 12/2002

Drug/Important Bio-Agent (IBA)

51	VaccinesIBA 10/2022 - 12/2002
27	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 11/2021 - 12/2006
11	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2021 - 12/2006
6	Poliovirus VaccinesIBA 01/2021 - 12/2006
3	Rubella VaccineIBA 01/2017 - 01/2016
2	Measles VaccineIBA 01/2016 - 01/2016
2	AntibodiesIBA 01/2016 - 01/2016
1	Hepatitis B e AntigensIBA 01/2017
1	Cholera Vaccines FDA Link 01/2016
1	AntigensIBA 01/2016
1	Pharmaceutical PreparationsIBA 09/2015
1	Antiviral Agents (Antivirals)IBA 09/2015
1	Vitamin A (Retinol)FDA LinkGeneric 12/2010
1	Hazardous Substances (Hazardous Materials)IBA 12/2006
1	neodymium pyrocatechin disulfonate (NPD)IBA 03/2003

Therapy/Procedure

1	Protective Devices (Safety Device) 03/2003